🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being done to measure the absorption of the DEXTENZA implant a...
Status
Completed
Location
Bucci Laser Vision
Start Date
2021-01-01
Trial ID
NCT04667507
Treatments Being Tested
The objective of the study was to evaluate the safety and efficacy of OTX-D...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02736175
Treatments Being Tested
The objective of the study was to evaluate the efficacy and safety of OTX-D...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02468700
Treatments Being Tested
The objective of the study was to evaluate the safety and efficacy of OTX-D...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02089113
Treatments Being Tested
To evaluate the safety and efficacy of Dextenza intracanalicular insert in ...
Status
Withdrawn
Location
Mass Eye and Ear
Start Date
2021-09
Trial ID
NCT04728646
Drug delivery platforms are an innovative exciting advancement in ophthalmo...
Status
Completed
Location
Illinois Eye Institute
Start Date
2020-09-01
Trial ID
NCT04418999
This prospective study will use a self controlled design for 35 eyes. Patie...
Status
Unknown
Location
Multiple Locations
Start Date
2021-01
Trial ID
NCT04530864
Treatments Being Tested
This prospective, open-label, single-center, randomized, investigator-spons...
Status
Completed
Location
Clinical Research Center of Florida
Start Date
2021-04-30
Trial ID
NCT04708821
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract...
Status
Completed
Location
Advanced Vision Care
Start Date
2023-06-01
Trial ID
NCT05626478
The Tender Study is a prospective, open-label, single-center, randomized, i...
Status
Completed
Location
Duke Eye Center
Start Date
2023-02-01
Trial ID
NCT05620901
Treatments Being Tested